Companies: 10,795·Total market cap: $144.5T
VectivBio Holding AG

VectivBio Holding AG

VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio
52W High$16.98
52W Low$4.25
Overview

VectivBio Holding AG (VECT) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · VECT · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2022-122021-122020-122019-12
Operating Activities
Net Income($93.73M)($87.01M)($59.94M)($23.48M)
Depreciation & Amort.$0.24M$0.30M$0.27M$0.15M
Stock-Based Comp.$16.77M$24.90M$5.45M$2.08M
Change in Working Capital$9.50M$1.19M$2.40M$4.97M
Net Cash from Operations($56.26M)($72.14M)($38.21M)($14.90M)
Investing Activities
Capital Expenditure($0.07M)($0.06M)($0.09M)($0.06M)
Purchases of Investments$0.00M$0.00M($0.01M)($0.00M)
Sales of Investments$0.00M$0.00M$0.00M$0.00M
Net Cash from Investing($0.07M)($6.67M)($0.07M)($0.04M)
Financing Activities
Common Stock Repurchased($0.01M)$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$0.00M$0.00M$0.00M$0.00M
Net Cash from Financing$175.06M$141.33M$56.59M$32.81M
Free Cash Flow
Free Cash Flow($56.33M)($72.20M)($38.30M)($14.95M)
FCF Margin %(computed)-206.04%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more VectivBio Holding AG data

About VectivBio Holding AG (VECT) Cash Flow Statement

VectivBio Holding AG generated operating cash flow of ($0.06B) and free cash flow of ($0.06B) for 2022 — a FCF margin of -206.04%. Capital expenditure was ($0.00B).

Frequently asked questions

VECT · 4 questions

VectivBio Holding AG generated free cash flow of ($0.06B) for 2022, up 22.0% year-over-year.

VECT free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10